| ARVO Home | Web Version | Mobile Version | Print-Friendly Version | Send to a Friend |
March 13, 2015





Manage ARVO e-News
Search Back Issues

Events and education
Make plans to attend diabetic retinopathy conference

Save the date for the upcoming research conference, Diabetic Retinopathy — Battling the Global Epidemic, to be held Aug. 27 – 28 in Bethesda, Md.

Be part of the discussion: NEI/FDA Endpoints Workshops
Register now to participate in the review of clinical trial considerations aimed at 
  • Inflammatory eye disease – March 26
  • Diabetic retinopathy – June 26
Community news
Federal court upholds the AETA
The latest lawsuit by animal rights extremists against the Animal Enterprise Terrorism Act was rejected in Illinois.
Members in the news
In memoriam
The ARVO community remembers colleague, Ronald M. Burde, MD.
Foundation news
Get your WEAVR Luncheon tickets while they last

Learn more about guest speaker Lilly Marks, vice president for Health Affairs, University of Colorado, who will present on the Art of Negotiation.

ARVO journals
IOVS spotlights conjunctival epithelial cells research

Read newly published articles in JOV and TVST.

Glaucoma surgeon needed in Colorado

Also, U.S. institutions seek faculty and research fellow candidates. 

Funding opportunities

ARVO Funding Guide is now a searchable database with over 200 opportunities listed.

  • Eye Bank Association of America Richard Lindstrom/EBAA Research Grant 
  • Canadian National Institute for the Blind Ross Purse Doctoral Fellowship
  • The Science & SciLifeLab Prize for Young Scientists
Association for Research in Vision and Ophthalmology
1801 Rockville Pike, Suite 400 | Rockville MD 20852-5622
tel: + | fax: + | arvo@arvo.org | www.arvo.org
You are receiving ARVO Insight as a member service or because of your involvement with ARVO.
If you do not wish to receive Insight, please unsubscribe.

View ARVO's Privacy Policy.

To ensure delivery of Insight, please add arvo@arvo.org to your e-mail address book or Safe Sender List.
If you are still having problems receiving our communications, get more information about white-listing.